BioNexus Gene Lab Corp. shareholders elect all four director nominees and approve 2025 equity plan

BioNexus Gene Lab Corp

Directors re-elected: Su-Leng Tan Lee, Muhammad Azrul bin Abdul Hamid, Jook Yuen Low, Chee Keong Yap.
2025 Equity Incentive Plan approved with 966,759.8 votes for, 10,628.5 against.
JP Centurion & Partners PLT ratified as independent auditor for FY 2025.
Adjournment proposal approved if needed to solicit additional proxies.
All proposals passed; meeting held December 24, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.